Hi John,

Following is the process we used when a change in wax was needed (different 
supplier, change in formulation etc).

Validation of tissue processing waxes
Changing processing and embedding waxes could improve or badly affect your 
histology quality. Your lab has years of experience with a particular wax and 
have developed and optimised stains (including immunohistochemistry) on tissues 
embedded in this wax. To change requires re-validation of all these stains.

  1.  Compare data sheet with old wax datasheet (melting point, additives).
  2.  Wax Purity Test

If components of the wax are not soluble in the clearing agent, then tissue 
samples will not be effectively infiltrated during processing nor will they 
dewax adequately for staining methods. The following test procedure has been 
recommended:

  1.  Take 1 gram of wax and mix in 20ml of xylene
  2.  Record time for full dissolution
  3.  Check for any undissolved residues and contaminants

  1.  Occurrence of nuclear birefringence

Incomplete wax removal can cause several problems including birefringence of 
cell nuclei (Vlachos 1968, Stain Technol. 43: 89–95), so-called pink disease in 
which the distribution of stains is patchy and distinct nuclear margins are 
lost, and weak to false negative immunohistochemical staining (Henwood 2012, 
Biotechnic & Histochemistry, 87(1), 46-50). Although there may be several 
causes of pink disease, one common cause is the incomplete removal of wax. It 
is commonly accepted that birefringent cell nuclei are due to incomplete wax 
removal by xylene (Vlachos 1968). Vlachos (1968) also noted that nuclear 
staining was weaker in areas that showed increased birefringence.
Using routine dewaxing and rehydration methods followed by observation using 
polarisation microscopy can indicate differences in wax properties that might 
require changes in dewaxing procedures prior to routine staining.

  1.  Tissue Wax Test

It is important to ensure that use of the wax results in well-processed blocks 
that are easy to section. Whenever a new wax is being assessed it is important 
that several tissues are used. I would recommend:

  *   Brain – a tissue rich in lipids and delicate neural fibres, can 6-7μm 
sections be easily sectioned?
  *   Liver – regular polyhedral cells bound in cords, that will show any 
variation in infiltration and possible shrinkage across the tissue
  *   Skin – a mix of keratinised squamous cells, elastic and connective tissue
  *   Tonsil or lymph node – how do the lymphoid cells appear especially when 
thin 2μm sections are cut?
  *   Appendix – a mix of delicate epithelial cells, collagen and muscle. Do 
stained sections exhibit folding of the epithelial cells due to excessive 
shrinkage?
  *   Kidney – what is the quality of 2μm sections?

  1.  It is important to compare the new wax with the old (ie run the tests in 
parallel).




Regards,



Tony Henwood MSc, BAppSc, GradDipSysAnalys, CT(ASC), FFSc(RCPA) (Retired)

Principal Scientist, the Children’s Hospital at Westmead (Retired)

Adjunct Fellow, School of Medicine, University of Western Sydney.

________________________________
From: John O’Brien via Histonet <[email protected]>
Sent: 11 March 2025 07:41
To: [email protected] <[email protected]>
Subject: [Histonet] Validation of parriffin

Histonetters
  ?When a new paraffin is introduced to a Tissue processor is validation 
required?
If so what is protocol?
Thank you
IMEB Inc

_______________________________________________
Histonet mailing list
[email protected]
http://lists.utsouthwestern.edu/mailman/listinfo/histonet
_______________________________________________
Histonet mailing list
[email protected]
http://lists.utsouthwestern.edu/mailman/listinfo/histonet

Reply via email to